City Therapeutics to Offer 9.7 Million Shares in US IPO

MT newswire2026/10/09 12:10

08:10 AM EDT, 10/09/2026 (MT Newswires) -- City Therapeutics filed a registration statement with the US Securities and Exchange Commission Friday for a proposed initial public offering of 9.7 million common shares, estimated to be priced at between $17 and $19 apiece. The company said it expects to raise net proceeds of $158.3 million from the offering. Proceeds could reach $182.7 million if underwriters exercise their option to buy an additional 1.5 million shares. City Therapeutics said it expects to use the proceeds to fund clinical trials, including for the treatment of Stargardt disease. The company said it has applied to list its stock on the Nasdaq Global Market under the "CTY" ticker symbol.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

The central bank has increased its gold reserves for 24 consecutive months, with October’s increase hitting a record high for the period.

新浪财经•2026/11/09 05:37

Trader Gu Jingci: November 9 Bitcoin/Ethereum Trading Strategy and Market Analysis

AiCoin•2026/11/09 05:35

Dow Jones Top Energy Headlines at 12 AM ET: Oil Futures Slide As Market Holds Out Hopes for Middle East Diplomacy | Energy ...

Dow Jones•2026/11/09 05:00

United States Dollar Index remains subdued as lower oil prices ease inflation pressure

FXStreet•2026/11/09 04:54